Neumora Therapeutics, Inc. Common Stock (NMRA) Insider Trading
Total insider buys:
- $61,619,186.74
Total insider sells:
- $0.00
Most recent insider trade:
- Nov. 14, 2023
Most active insider trader:
- Kristina Burow
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 14, 2023 | Major Shareholder | 3,357 | $11.98 | Buy | $40,216.86 | |
Nov. 13, 2023 | Director | 31,653 | $11.75 | Buy | $371,922.75 | |
Nov. 10, 2023 | Director | 17,275 | $11.49 | Buy | $198,489.75 | |
Nov. 9, 2023 | Major Shareholder | 31,079 | $10.53 | Buy | $327,261.87 | |
Nov. 8, 2023 | Director | 92,251 | $11.03 | Buy | $1,017,528.53 | |
Nov. 7, 2023 | Major Shareholder | 30,192 | $11.50 | Buy | $347,208.00 | |
Nov. 6, 2023 | Director | 43,082 | $11.55 | Buy | $497,597.10 | |
Nov. 3, 2023 | Director | 22,420 | $11.38 | Buy | $255,139.60 | |
Sept. 29, 2023 | Major Shareholder | 34,560 | $13.98 | Buy | $483,148.80 | |
Sept. 28, 2023 | Director | 41,951 | $13.44 | Buy | $563,821.44 | |
Sept. 27, 2023 | Major Shareholder | 24,504 | $12.31 | Buy | $301,644.24 | |
Sept. 26, 2023 | Director | 34,000 | $11.73 | Buy | $398,820.00 | |
Sept. 25, 2023 | Major Shareholder | 60,740 | $11.22 | Buy | $681,502.80 | |
Sept. 22, 2023 | Major Shareholder | 40,000 | $11.14 | Buy | $445,600.00 | |
Sept. 19, 2023 | Major Shareholder | 1,764,705 | $17.00 | Buy | $29,999,985.00 | |
Sept. 19, 2023 | Director | 1,500,000 | $17.00 | Buy | $25,500,000.00 | |
Sept. 19, 2023 | CEO | 15,000 | $12.62 | Buy | $189,300.00 |
First«1 of 1»Last
Insiders are buying Neumora Therapeutics, Inc. Common Stock stock.
The insider traders at Neumora Therapeutics, Inc. Common Stock are: Kristina Burow, Arch Venture Partners Xii, Llc, Amgen Inc, and Henry O Gosebruch
The most active insider trader at Neumora Therapeutics, Inc. Common Stock is Kristina Burow with 8 trades.
Amgen Inc has bought the most Neumora Therapeutics, Inc. Common Stock stock with a total value of $59,999,970.00.
The most recent insider trade for Neumora Therapeutics, Inc. Common Stock was on Nov. 14, 2023.
The single biggest insider buy for Neumora Therapeutics, Inc. Common Stock was from Amgen Inc with a total value of $29,999,985.00 on Sept. 19, 2023.